TickerFacts.

Enveric Biosciences, Inc. (ENVB): Gross Profit

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Gross Profit is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$8.15M
Year ended 2019-12-31
+5.6%
3-year compound annual growth
$10.24M2015-12-31: $6.87M2016-12-31: $6.93M2017-12-31: $10.24M2018-12-31: $8.98M2019-12-31: $8.15M$8.15M
2015-12-31 Gross Profit (USD) 2019-12-31
Period endedGross ProfitChange YoYSource filing
2019-12-31$8.15M-9.3%2020-08-12, From 2019-01-01
2018-12-31$8.98M-12.3%2020-08-12, From 2018-01-01
2017-12-31$10.24M+47.8%2019-03-26, From 2017-01-01
2016-12-31$6.93Mn/c2018-04-02, From 2016-01-01
2015-12-31$6.87Mn/a2017-04-04, From 2015-01-01